The conference will deal with end organ damage induced by cardiovascular risk factors- Hypertension, Diabetes, Dyslipidemia and Obesity, their early diagnosis and treatment. We will discuss the early mechanisms of damage and treatment of coronary heart disease, cerebrovascular disease, management of lipids, renal failure and peripheral artery disease. This conference will also focus on the significance of prehypertension and hypertension especially when additional risk factors and the cardio metabolic syndrome are present.

Latvian Society of Cardiology was founded in 1992, with the aim of promoting the development of Latvian Cardiology. LSC is to provide effective training for doctors and nurses, to organize courses, seminars, scientific conferences, training - both existing and future cardiologists and cardiology nurses. The association also deals with the recommendations and guidance for cardiologist, internist and family physicians, such as acute coronary syndrome. Evaluation of hypertension and treatment guidelines cardiovascular disease prevention guidelines and others. Annually Latvian Society of Cardiology is participating from 8 to 10 Latvian-wide and international seminars, conferences and congresses, and creating thematic organization. The Society also supports a variety of heart health promotion activities, like the World Heart day, which for many years is celebrated in the end of September in Riga centre. In 1992 Latvian Society of Cardiology was admitted in the European Society of Cardiology.

As a new highlight of Chinese economy, the mushrooming Big Health Market has immeasurable potentials to achieve a size of over RMB 8,000 billion by 2020, predicted CIConsulting. Tapping into China’s growing demand for high-quality wellness & health products, Wellness China targets at both the general public as well as professionals, covering an exhibition area of 15,000 sqm.

The Pharma Times provides with the latest breaking news and videos straight from the Pharma industry including in depth coverage, news, views, reviews market dynamics, research and design of this industry.

We are pleased to announce that JIM 2019 will be held on February 14 – 26, 2019 in Milano, Italy. This International Course of Interventional Cardiology as usual will be mainly concentrated on the practical and educational aspects associated with case demonstrations and more emphasis will be given to the learning process and to live cases. During the meeting there will be “State of the Art” Symposia with experts in the field.

At our Innovating Care – Transforming Nursing Care (ICTNC) conferences, we aim to open important discussions on and drive thought leadership across the areas of nursing leadership, promotion of nursing knowledge, and nursing care innovation that can enhance coordination of patient care, improve clinical outcomes, increase patient satisfaction, and improve physician collaboration. We aim to redefine the role of nursing in the Continuum of Care while redesigning the patient experience from Hospital to Community to Home. Go beyond the role of caregiver, become key integrators and efficiency experts.

Left atrial appendage closure for stroke prevention in atrial fibrillation is a good alternative to anticoagulation therapy. Learn everything you need to know about LAA closure at this workshop! 

CSI Africa is a 2-day course, designed to give attendees an overview of the most important catheter therapies of congenital, structural and valvar heart disease in children and adults. It is aimed in particular at physicians from the African continent.

Heart failure is the next frontier in cardiovascular interventions. We will be discussing new approaches to treat heart failure in the context of the 2016 ESC clinical practice guidelines.

Focused on practice in the Asia-Pacific region, this meeting will give a comprehensive overview of major topics in catheter therapy of congenital, structural and valvular heart disease.

Join us in Frankfurt, Germany, for a unique learning experience in catheter interventions for congenital, structural and valvar heart disease, with the scientific program featuring state-of-the-art lectures and live case transmissions with experienced operators.